참고문헌 (57)

1. Won, Soyoung, Cho, Soo-Kyung, Kim, Dam, Han, Minkyung, Lee, Jiyoung, Jang, Eun Jin, Sung, Yoon-Kyoung, Bae, Sang-Cheol. Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization. Rheumatology international, vol.38, no.4, 649-656.

   상세보기

2. Regulation on approval and review of biological products [Internet] Ministry of Food and 2019 

3. 10.18553/jmcp.2011.17.s9-b.s14 

   

4. Cho, Soo-Kyung, Sung, Yoon-Kyoung. Treatment strategy for patients with rheumatoid arthritis. JKMA : Journal of the Korean Medical Association = 대한의사협회지, vol.63, no.7, 422-430.

   상세보기

5. Chung, Eugene S., Packer, Milton, Lo, Kim Hung, Fasanmade, Adedigbo A., Willerson, James T.. Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure : Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial. Circulation, vol.107, no.25, 3133-3140.

   상세보기

6. Singh, J.A., Cameron, C., Noorbaloochi, S., Cullis, T., Tucker, M., Christensen, R., Ghogomu, E.T., Coyle, D., Clifford, T., Tugwell, P., Wells, G.A.. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. The Lancet, vol.386, no.9990, 258-265.

   상세보기

7. Lahiri, M., Dixon, W.G.. Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis. Best practice & research. Clinical rheumatology, vol.29, no.2, 290-305.

   상세보기

8. Singh, Jasvinder A., Saag, Kenneth G., Bridges Jr., S. Louis, Akl, Elie A., Bannuru, Raveendhara R., Sullivan, Matthew C., Vaysbrot, Elizaveta, McNaughton, Christine, Osani, Mikala, Shmerling, Robert H., Curtis, Jeffrey R., Furst, Daniel E., Parks, Deborah, Kavanaugh, Arthur, O'Dell, James, King, Charles, Leong, Amye, Matteson, Eric L., Schousboe, John T., Drevlow, Barbara, Ginsberg, Seth, Grober, James, St.Clair, E. William, Tindall, Elizabeth, Miller, Amy S., McAlindon, Timothy. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis & rheumatology, vol.68, no.1, 1-26.

   상세보기

9. Burmester, Gerd R, Rubbert-Roth, Andrea, Cantagrel, Alain, Hall, Stephen, Leszczynski, Piotr, Feldman, Daniel, Rangaraj, Madura J, Roane, Georgia, Ludivico, Charles, Bao, Min, Rowell, Lucy, Davies, Claire, Mysler, Eduardo F. Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Annals of the rheumatic diseases : the official journal, vol.75, no.1, 68-74.

   상세보기

10. Strangfeld, A, Richter, A, Siegmund, B, Herzer, P, Rockwitz, K, Demary, W, Aringer, M, Meißner, Y, Zink, A, Listing, J. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. Annals of the rheumatic diseases : the official journal, vol.76, no.3, 504-510.

    상세보기

11. Aletaha, Daniel, Bingham III, Clifton O, Tanaka III, Yoshiya, Agarwal III, Prasheen, Kurrasch III, Regina, Tak III, Paul P, Popik III, Sharon. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study. The Lancet, vol.389, no.10075, 1206-1217.

    상세보기

12. Takeuchi, Tsutomu, Tanaka, Yoshiya, Yamanaka, Hisashi, Amano, Kanzo, Nagamine, Ryuji, Park, Won, Shiozawa, Kazuko, Tsukano, Michishi, Wei, James Cheng-Chung, Shao, Jing, Togo, Osamu, Mashimo, Hideki. Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial. Modern Rheumatology, vol.26, no.1, 15-23.

    상세보기

13. Jones, G, Sebba, A, Gu, J, Lowenstein, M B, Calvo, A, Gomez-Reino, J J, Siri, D A, Tomšič, M, Alecock, E, Woodworth, T, Genovese, M C. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Annals of the rheumatic diseases : the official journal, vol.69, no.1, 88-96.

    상세보기

14. on behalf of the ADACTA Study Investigators, Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., Kavanaugh, A.. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. The Lancet, vol.381, no.9877, 1541-1550.

    상세보기

15. Smolen, Josef S, Landewé, Robert B M, Bijlsma, Johannes W J, Burmester, Gerd R, Dougados, Maxime, Kerschbaumer, Andreas, McInnes, Iain B, Sepriano, Alexandre, van Vollenhoven, Ronald F, de Wit, Maarten, Aletaha, Daniel, Aringer, Martin, Askling, John, Balsa, Alejandro, Boers, Maarten, den Broeder, Alfons A, Buch, Maya H, Buttgereit, Frank, Caporali, Roberto, Cardiel, Mario Humberto, De Cock, Diederik, Codreanu, Catalin, Cutolo, Maurizio, Edwards, Christopher John, van Eijk-Hustings, Yvonne, Emery, Paul, Finckh, Axel, Gossec, Laure, Gottenberg, Jacques-Eric, Hetland, Merete Lund, Huizinga, Tom W J, Koloumas, Marios, Li, Zhanguo, Mariette, Xavier, Mu¨ller-Ladner, Ulf, Mysler, Eduardo F, da Silva, Jose A P, Poór, Gyula, Pope, Janet E, Rubbert-Roth, Andrea, Ruyssen-Witrand, Adeline, Saag, Kenneth G, Strangfeld, Anja, Takeuchi, Tsutomu, Voshaar, Marieke, Westhovens, René, van der Heijde, Désirée. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases : the official journal, vol.79, no.6, 685-699.

    상세보기

16. Genovese, Mark C., Becker, Jean-Claude, Schiff, Michael, Luggen, Michael, Sherrer, Yvonne, Kremer, Joel, Birbara, Charles, Box, Jane, Natarajan, Kannan, Nuamah, Isaac, Li, Tracy, Aranda, Richard, Hagerty, David T., Dougados, Maxime. Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition. The New England journal of medicine, vol.353, no.11, 1114-1123.

    상세보기

17. Park 135 2018 

18. Bonelli, M., Ferner, E., Göschl, L., Blüml, S., Hladik, A., Karonitsch, T., Kiener, H. P., Byrne, R., Niederreiter, B., Steiner, C. W., Rath, E., Bergmann, M., Smolen, J. S., Scheinecker, C.. Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis. Arthritis and rheumatism, vol.65, no.3, 599-607.

    상세보기

19. Cohen, Stanley B., Emery, Paul, Greenwald, Maria W., Dougados, Maxime, Furie, Richard A., Genovese, Mark C., Keystone, Edward C., Loveless, James E., Burmester, Gerd-Rüdiger, Cravets, Matthew W., Hessey, Eva W., Shaw, Timothy, Totoritis, Mark C.. Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis and rheumatism, vol.54, no.9, 2793-2806.

    상세보기

20. 10.1093/infdis/jiw606 

    

21. Molloy, Eamonn S., Calabrese, Cassandra M., Calabrese, Leonard H.. The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era. Rheumatic diseases clinics of North America, vol.43, no.1, 95-109.

    상세보기

22. Abushouk, Abdelrahman Ibrahim, Ahmed, Hussien, Ismail, Ammar, Elmaraezy, Ahmed, Badr, Ahmed Said, Gadelkarim, Mohamed, Elnenny, Mohammed. Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis. Rheumatology international, vol.37, no.7, 1053-1064.

    상세보기

23. Taylor, Peter C, Quattrocchi, Emilia, Mallett, Stephen, Kurrasch, Regina, Petersen, Jørgen, Chang, David J. Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial. Annals of the rheumatic diseases : the official journal, vol.70, no.12, 2119-2125.

    상세보기

24. Hamilton, John A. GM-CSF as a target in inflammatory/autoimmune disease: current evidence and future therapeutic potential. Expert review of clinical immunology, vol.11, no.4, 457-465.

    상세보기

25. Behrens, Frank, Tak, Paul P, Østergaard, Mikkel, Stoilov, Rumen, Wiland, Piotr, Huizinga, Thomas W, Berenfus, Vadym Y, Vladeva, Stoyanka, Rech, Juergen, Rubbert-Roth, Andrea, Korkosz, Mariusz, Rekalov, Dmitriy, Zupanets, Igor A, Ejbjerg, Bo J, Geiseler, Jens, Fresenius, Julia, Korolkiewicz, Roman P, Schottelius, Arndt J, Burkhardt, Harald. MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial. Annals of the rheumatic diseases : the official journal, vol.74, no.6, 1058-1064.

    상세보기

26. A randomised trial evaluating anakinra in early active rheumatoid arthritis Scott 88 2016 

27. Smolen, Josef S, Agarwal, Sandeep K, Ilivanova, Elena, Xu, Xie Lillian, Miao, Ye, Zhuang, Yanli, Nnane, Ivo, Radziszewski, Waldemar, Greenspan, Andrew, Beutler, Anna, Baker, Daniel. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Annals of the rheumatic diseases : the official journal, vol.76, no.5, 831-839.

    상세보기

28. 10.1002/1529-0131(199905)42 

    

29. Genovese, Mark C, Durez, Patrick, Richards, Hanno B, Supronik, Jerzy, Dokoupilova, Eva, Mazurov, Vadim, Aelion, Jacob A, Lee, Sang-Heon, Codding, Christine E, Kellner, Herbert, Ikawa, Takashi, Hugot, Sophie, Mpofu, Shephard. Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study. Annals of the rheumatic diseases : the official journal, vol.72, no.6, 863-869.

    상세보기

30. Martin, David A, Churchill, Melvin, Flores-Suarez, Luis Felipe, Cardiel, Mario H, Wallace, Daniel, Martin, Richard, Phillips, Kristine, Kaine, Jeffrey L, Dong, Hua, Salinger, David, Stevens, Erin, Russell, Chris B, Chung, James B. A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis. Arthritis research & therapy, vol.15, no.5, R164-R164.

    상세보기

31. Genovese, Mark C., Greenwald, Maria, Cho, Chul‐Soo, Berman, Alberto, Jin, Ling, Cameron, Gregory S., Benichou, Olivier, Xie, Li, Braun, Daniel, Berclaz, Pierre‐Yves, Banerjee, Subhashis. A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti–Interleukin‐17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors. Arthritis & rheumatology, vol.66, no.7, 1693-1704.

    상세보기

32. Lopez-Pedrera, Chary, Barbarroja, Nuria, Patiño-Trives, Alejandra M., Luque-Tévar, Maria, Collantes-Estevez, Eduardo, Escudero-Contreras, Alejandro, Pérez-Sánchez, Carlos. Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis. International journal of molecular sciences, vol.21, no.23, 9067-.

    상세보기

33. Braun, J., Kästner, P., Flaxenberg, P., Währisch, J., Hanke, P., Demary, W., von Hinüber, U., Rockwitz, K., Heitz, W., Pichlmeier, U., Guimbal-Schmolck, C., Brandt, A.. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial. Arthritis and rheumatism, vol.58, no.1, 73-81.

    상세보기

34. Nikiphorou, Elena, Negoescu, Andra, Fitzpatrick, John D., Goudie, Calum T., Badcock, Andrew, Östör, Andrew J. K., Malaviya, Anshuman P.. Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort. Clinical rheumatology, vol.33, no.5, 609-614.

    상세보기

35. Soliman, Moetaza M, Ashcroft, Darren M, Watson, Kath D, Lunt, Mark, Symmons, Deborah P M, Hyrich, Kimme L. Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Annals of the rheumatic diseases : the official journal, vol.70, no.4, 583-589.

    상세보기

36. Cost-minimization analysis of biologic disease-modifying antirheumatic drugs administered by subcutaneous injections in patients with rheumatoid arthritis Park 59 2016 

37. Smolen, Josef S, Breedveld, Ferdinand C, Burmester, Gerd R, Bykerk, Vivian, Dougados, Maxime, Emery, Paul, Kvien, Tore K, Navarro-Compán, M Victoria, Oliver, Susan, Schoels, Monika, Scholte-Voshaar, Marieke, Stamm, Tanja, Stoffer, Michaela, Takeuchi, Tsutomu, Aletaha, Daniel, Andreu, Jose Louis, Aringer, Martin, Bergman, Martin, Betteridge, Neil, Bijlsma, Hans, Burkhardt, Harald, Cardiel, Mario, Combe, Bernard, Durez, Patrick, Fonseca, Joao Eurico, Gibofsky, Alan, Gomez-Reino, Juan J, Graninger, Winfried, Hannonen, Pekka, Haraoui, Boulos, Kouloumas, Marios, Landewe, Robert, Martin-Mola, Emilio, Nash, Peter, Ostergaard, Mikkel, Östör, Andrew, Richards, Pam, Sokka-Isler, Tuulikki, Thorne, Carter, Tzioufas, Athanasios G, van Vollenhoven, Ronald, de Wit, Martinus, van der Heijde, Desirée. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Annals of the rheumatic diseases : the official journal, vol.75, no.1, 3-15.

    상세보기

38. Smolen, J.S., Burmester, G.R., Combe, B., Curtis, J.R., Hall, S., Haraoui, B., van Vollenhoven, R., Cioffi, C., Ecoffet, C., Gervitz, L., Ionescu, L., Peterson, L., Fleischmann, R.. Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study. The Lancet, vol.388, no.10061, 2763-2774.

    상세보기

39. Weinblatt, M., Combe, B., Covucci, A., Aranda, R., Becker, J. C., Keystone, E.. Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study. Arthritis and rheumatism, vol.54, no.9, 2807-2816.

    상세보기

40. Genovese, Mark C., Cohen, Stanley, Moreland, Larry, Lium, Deborah, Robbins, Sean, Newmark, Richard, Bekker, Pirow. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. Arthritis and rheumatism, vol.50, no.5, 1412-1419.

    상세보기

41. Greenwald, Maria W., Shergy, William J., Kaine, Jeffrey L., Sweetser, Marianne T., Gilder, Kye, Linnik, Matthew D.. Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial. Arthritis and rheumatism, vol.63, no.3, 622-632.

    상세보기

42. Wang, Yunxin, Wu, Qiang, Liu, Zhihang, Guo, Xiaochen, Zhou, Lijiao, Wang, Yuyang, Song, Liying, Wang, Nan, Zheng, Qi, Wang, Wenfei, Ren, Guiping, Li, Deshan. A recombinant IgG-like bispecific antibody acting as interleukin-1β and interleukin-17A inhibitor exhibits a promising efficacy for rheumatoid arthritis. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie, vol.89, 426-437.

    상세보기

43. Haschka, Judith, Englbrecht, Matthias, Hueber, Axel J, Manger, Bernhard, Kleyer, Arnd, Reiser, Michaela, Finzel, Stephanie, Tony, Hans-Peter, Kleinert, Stefan, Feuchtenberger, Martin, Fleck, Martin, Manger, Karin, Ochs, Wolfgang, Schmitt-Haendle, Matthias, Wendler, Joerg, Schuch, Florian, Ronneberger, Monika, Lorenz, Hanns-Martin, Nuesslein, Hubert, Alten, Rieke, Demary, Winfried, Henes, Joerg, Schett, Georg, Rech, Juergen. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study. Annals of the rheumatic diseases : the official journal, vol.75, no.1, 45-51.

    상세보기

44. Smolen, J.S., Nash, P., Durez, P., Hall, S., Ilivanova, E., Irazoque-Palazuelos, F., Miranda, P., Park, M.C., Pavelka, K., Pedersen, R., Szumski, A., Hammond, C., Koenig, A.S., Vlahos, B.. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. The Lancet, vol.381, no.9870, 918-929.

    상세보기

45. van Herwaarden, Noortje, van der Maas, Aatke, Minten, Michiel J M, van den Hoogen, Frank H J, Kievit, Wietske, van Vollenhoven, Ronald F, Bijlsma, Johannes W J, van den Bemt, Bart J F, den Broeder, Alfons A. Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial. BMJ : British medical journal, vol.350, h1389-.

    상세보기

46. Nam, Jackie L, Takase-Minegishi, Kaoru, Ramiro, Sofia, Chatzidionysiou, Katerina, Smolen, Josef S, van der Heijde, Désiréée, Bijlsma, Johannes W, Burmester, Gerd R, Dougados, Maxime, Scholte-Voshaar, Marieke, van Vollenhoven, Ronald, Landewééé, Robert. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the rheumatic diseases : the official journal, vol.76, no.6, 1113-1136.

    상세보기

47. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship Carter 1014 2006 

48. Diav-Citrin, O., Otcheretianski-Volodarsky, A., Shechtman, S., Ornoy, A.. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study. Reproductive toxicology, vol.43, 78-84.

    상세보기

49. Sammaritano, Lisa R., Bermas, Bonnie L., Chakravarty, Eliza E., Chambers, Christina, Clowse, Megan E. B., Lockshin, Michael D., Marder, Wendy, Guyatt, Gordon, Branch, D. Ware, Buyon, Jill, Christopher‐Stine, Lisa, Crow‐Hercher, Rachelle, Cush, John, Druzin, Maurice, Kavanaugh, Arthur, Laskin, Carl A., Plante, Lauren, Salmon, Jane, Simard, Julia, Somers, Emily C., Steen, Virginia, Tedeschi, Sara K., Vinet, Evelyne, White, C. Whitney, Yazdany, Jinoos, Barbhaiya, Medha, Bettendorf, Brittany, Eudy, Amanda, Jayatilleke, Arundathi, Shah, Amit Aakash, Sullivan, Nancy, Tarter, Laura L., Birru Talabi, Mehret, Turgunbaev, Marat, Turner, Amy, D'Anci, Kristen E.. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis & rheumatology, vol.72, no.4, 529-556.

    상세보기

50. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study Mariette 228 2018 

51. Choe, Jung-Yoon, Prodanovic, Nenad, Niebrzydowski, Jaroslaw, Staykov, Ivan, Dokoupilova, Eva, Baranauskaite, Asta, Yatsyshyn, Roman, Mekic, Mevludin, Porawska, Wieskawa, Ciferska, Hana, Jedrychowicz-Rosiak, Krystyna, Zielinska, Agnieszka, Choi, Jasmine, Rho, Young Hee, Smolen, Josef S. A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases : the official journal, vol.76, no.1, 58-64.

    상세보기

52. Yoo, Dae Hyun, Racewicz, Artur, Brzezicki, Jan, Yatsyshyn, Roman, Arteaga, Edgardo Tobias, Baranauskaite, Asta, Abud-Mendoza, Carlos, Navarra, Sandra, Kadinov, Vladimir, Sariego, Irmgadt Goecke, Hong, Seung Suh, Lee, Sung Young, Park, Won. A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study. Arthritis research & therapy, vol.18, 82-.

    상세보기

53. Emery, Paul, Vencovský, Jiří, Sylwestrzak, Anna, Leszczyński, Piotr, Porawska, Wieslawa, Baranauskaite, Asta, Tseluyko, Vira, Zhdan, Vyacheslav M, Stasiuk, Barbara, Milasiene, Roma, Barrera Rodriguez, Aaron Alejandro, Cheong, Soo Yeon, Ghil, Jeehoon. A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy. Annals of the rheumatic diseases : the official journal, vol.76, no.1, 51-57.

    상세보기

54. Askling, Johan, Bongartz, Tim. Malignancy and biologic therapy in rheumatoid arthritis. Current opinion in rheumatology, vol.20, no.3, 334-339.

    상세보기

55. Ramiro, Sofia, Sepriano, Alexandre, Chatzidionysiou, Katerina, Nam, Jackie L, Smolen, Josef S, van der Heijde, Désiréée, Dougados, Maxime, van Vollenhoven, Ronald, Bijlsma, Johannes W, Burmester, Gerd R, Scholte-Voshaar, Marieke, Falzon, Louise, Landewééé, Robert B M. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the rheumatic diseases : the official journal, vol.76, no.6, 1101-1136.

    상세보기

56. Lee, Jeong-Eun, Shim, Da-Young, Yoon, Dongwon, Noh, Yunha, Shin, Ju-Young. Current status and examples of patient registries in the US, Europe, and Japan and proposal of planning patient registry in Korea. 약학회지 = Yakhak hoeji, vol.64, no.5, 358-368.

    상세보기

57. AB1066 Korean Biologics Registry of patients with systemic rheumatic disease (KOBIO): a nationwide registry to assess adverse events associated with biologic treatment in Korea [abstract] Shin 1153 2014